Takara Bio Inc. (OTCMKTS:TKBIF – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 7,988 shares, a drop of 90.1% from the April 30th total of 80,646 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days.
Takara Bio Price Performance
Takara Bio stock opened at $7.30 on Friday. Takara Bio has a fifty-two week low of $5.00 and a fifty-two week high of $7.30. The stock has a 50-day simple moving average of $7.30 and a 200-day simple moving average of $12.13.
About Takara Bio
Takara Bio Inc, a subsidiary of Takara Holdings Inc, is a global provider of innovative biotechnological products and services. Headquartered in Kusatsu, Shiga, Japan, the company specializes in developing and marketing reagents and instruments for molecular biology, cell biology and genomic research. With roots tracing back to Takara Shuzo Co, Ltd.’s life sciences division, Takara Bio has leveraged decades of experience to support scientific discovery and biopharmaceutical development.
Takara Bio’s core offerings include polymerase chain reaction (PCR) enzymes and kits, DNA and RNA purification systems, cloning and gene expression reagents, and advanced genome editing tools such as CRISPR/Cas systems.
Featured Stories
- Five stocks we like better than Takara Bio
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
- Wall Street Is Starting to Talk About Tesla’s Endgame
- Meta’s Manus Mess: Why China Blocked the Deal and What It Means
Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.
